{
    "Clinical Trial ID": "NCT02550795",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Control",
        "  administration of 0.9% normal saline 10ml",
        "  Control: administration of normal saline",
        "INTERVENTION 2: ",
        "  Dexmedetomidine",
        "  administration of 0.5ug/kg of dexmedetomidine (5ml)",
        "  Dexmedetomidine: administration of dexmedetomidine only"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  ASA Physical status I or II female scheduled for breast conserving surgery of modified radical mastectomy.",
        "Exclusion Criteria:",
        "  uncontrolled cardiovascular disease",
        "  history of chronic pain",
        "  smoker",
        "  previous history of steroid administraion",
        "  neoajuvant chemotherapy"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Postoperative Nausea (Numeric Rating Scale for Nausea)",
        "  Numeric rating scale for postoperative nausea (scores on a scale) (0-no symptoms; 10-worst symptoms imaginable). Ramosetron 0.3 mg was administered to patients with nausea >5 points on the numeric rating scale",
        "  Time frame: Changes from baseline in postoperative nausea at 30 min",
        "Results 1: ",
        "  Arm/Group Title: Control",
        "  Arm/Group Description: administration of 0.9% normal saline 10ml",
        "  Control: administration of normal saline",
        "  Overall Number of Participants Analyzed: 50",
        "  Median (Inter-Quartile Range)",
        "  Unit of Measure: scores on a scale  0        (0 to 0.25)",
        "Results 2: ",
        "  Arm/Group Title: Dexmedetomidine",
        "  Arm/Group Description: administration of 0.5ug/kg of dexmedetomidine (5ml)",
        "  Dexmedetomidine: administration of dexmedetomidine only",
        "  Overall Number of Participants Analyzed: 49",
        "  Median (Inter-Quartile Range)",
        "  Unit of Measure: scores on a scale  0        (0 to 0)"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/50 (0.00%)",
        "Adverse Events 2:",
        "  Total: 0/50 (0.00%)"
    ]
}